The Texas A&M Board of Regents learned how its support was being used as three professors presented on their research during ...

The mystery of the so-called Havana Syndrome has stumped experts, intelligence officials and lawmakers for close to a decade. More than 1,000 officials and their family members are thought to have ...

With a pair of Phase III trial flops, Ultragenyx will explore cost reductions as analysts turn attention to an upcoming Angelman syndrome readout. Ultragenyx lost $1 billion in value after a genetic ...

The Pinball Lounge at 78th Street Sudios offers an ideal setting for this unique fundraiser. The event runs from 4-6 pm, providing families with an accessible Sunday afternoon activity. True to its ...

Fatigue can stem from a variety of illnesses and life stressors, but when that exhaustion lasts for months — often following an infection — it may indicate a condition called chronic fatigue syndrome.

Ionis Pharmaceuticals, which is developing a treatment for the rare neurological disease of Angelman syndrome (AS), turned to Lifetime Television’s “Behind the Mystery” series to increase public ...

Manhattan-based psychotherapist Jonathan Alpert told Fox News on Friday that "Trump Derangement Syndrome" (TDS) is a real psychological issue he has seen firsthand in his practice, with three-quarters ...

Tourette syndrome often begins in childhood. But for many patients, its challenges and care needs continue into adulthood. From early recognition and behavioral interventions to managing transitions ...

MIDDLETON, Mass., Sept. 22, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...

On Tuesday, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation to Ionis Pharmaceuticals Inc.’s (NASDAQ:IONS) ION582 for Angelman syndrome (AS), a rare neurological ...

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ionis Pharmaceuticals, Inc. (IONS) (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...